admin, Author at Integral Molecular

Published by

Integral Molecular Partners with Merus to Discover Novel Therapeutic Monoclonal Antibodies

PHILADELPHIA – (BUSINESS WIRE) – Integral Molecular, the industry leader in the discovery of monoclonal antibodies (MAbs) against membrane proteins, and Merus N.V. (Nasdaq:MRUS), […]

Published by

Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection

SAPHIRE, ET AL. 2018. CELL 174(4):938-952 Read More […]

Published by

Reporter Virus Particles

SARS-CoV-2 Reporter Virus Particles (RVPs) Read More […]

Published by

Integral Molecular Celebrates Epitope Mapping Milestone of 1,000 Epitopes

PHILADELPHIA-(BUSINESS WIRE)-Integral Molecular, the industry leader in the discovery and characterization of antibodies against membrane proteins, celebrates a milestone of mapping 1,000 epitopes for […]

Published by

Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2–MPER region

FLYAK. 2018. NATURE MICROBIOLOGY 3, 670-677. Read More […]

Published by

Integral Molecular’s MPS Antibody Discovery Platform Yields Therapeutic Assets for Oncology and Metabolic Syndrome

Integral Molecular, the industry leader in membrane protein antibody discovery, announces the development of antibody assets targeting membrane proteins important in oncology (Claudin 6) […]

Published by

Integral Molecular’s Protein Engineering Technology Facilitates HIV Vaccine Development

PHILADELPHIA–(BUSINESS WIRE)-Integral Molecular, the industry leader in engineering membrane proteins, has extended its protein engineering capabilities to stabilize viral proteins and produce more effective […]

Published by

High-throughput Protein Engineering Improves the Antigenicity and Stability of Soluble HIV-1 Envelope Glycoprotein SOSIP Trimers

SULLIVAN, ET AL. 2017. J VIROL 91(22), E00862-17. Read More […]

Published by

Probing the antigenicity of hepatitis C virus envelope glycoprotein complex by high-throughput mutagenesis

GOPAL, ET AL. 2017. PLOS PATHOGENS 13(12), E1006735. Read More […]

Author: admin

Integral Molecular Partners with Merus to Discover Novel Therapeutic Monoclonal Antibodies

Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection

Reporter Virus Particles

Integral Molecular Celebrates Epitope Mapping Milestone of 1,000 Epitopes

Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2–MPER region

Integral Molecular’s MPS Antibody Discovery Platform Yields Therapeutic Assets for Oncology and Metabolic Syndrome

Integral Molecular’s Protein Engineering Technology Facilitates HIV Vaccine Development

High-throughput Protein Engineering Improves the Antigenicity and Stability of Soluble HIV-1 Envelope Glycoprotein SOSIP Trimers

Probing the antigenicity of hepatitis C virus envelope glycoprotein complex by high-throughput mutagenesis

Quick Links

Solutions

Contact Us